STAT

Opinion: 5 tips for creating effective biotech partnerships

I've been on both sides of forging biotech partnerships. Here are five tips for creating good ones.

The J.P. Morgan Healthcare Conference is like the Olympics for biotechnology entrepreneurs. Every January, small companies with big ideas go for the gold: the chance to see their innovation, hard work, and talent recognized and rewarded with the resources they need to move forward.

As the show kicks off, entrepreneurs naturally focus on how to win the attention of major players who can offer the capital, scientific expertise, and development experience it takes to turn a promising innovation into a successful medicine — or, better yet, to completely change the way the industry thinks about therapy.

As someone who led small private and public biotechs before joining

You're reading a preview, sign up to read more.

More from STAT

STAT1 min readSociety
Listen: A J.P. Morgan Recap, A Plan To Bust Pharma Monopolies, And A Website For Cancer Patients
Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find? Find out on the latest…
STAT4 min readSociety
‘How Long Do I Have?’ A Website On Cancer Survival Rates, From The Co-founder Of GoodRx, Seeks To Provide Clarity
A new online tool from the co-founder of GoodRx seeks to answer a simple but daunting question for cancer patients: "How long do I have?"
STAT4 min readSociety
Opinion: Why Black Doctors Like Me Are Leaving Faculty Positions In Academic Medical Centers
It's ironic that Black faculty members are unfairly tasked with the complex and overwhelming chore of remedying the structural outcomes of centuries of institutionalized racism in medicine that they did…